Page last updated: 2024-10-24

cefuroxime and Heart Valve Diseases

cefuroxime has been researched along with Heart Valve Diseases in 2 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).

Research Excerpts

ExcerptRelevanceReference
" The Ministry of Health has recently alerted practitioners to the possible risk of heart valve damage following the long-term use of weight-loss drugs fenfluramine (Ponderax) and dexfenfluramine (Adifax)."1.30Prevention of infective endocarditis associated with dental treatment and other medical interventions. National Heart Foundation. ( Ellis-Pegler, RB; Hay, KD; Lang, SD; Neutze, JM; Swinburn, BA, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geroulanos, S1
Oxelbark, S1
Turina, M1
Ellis-Pegler, RB1
Hay, KD1
Lang, SD1
Neutze, JM1
Swinburn, BA1

Trials

1 trial available for cefuroxime and Heart Valve Diseases

ArticleYear
[A prospective, randomized comparative study between cefazolin and cefuroxime as perioperative antibiotic prevention in cardiovascular surgery].
    Schweizerische medizinische Wochenschrift, 1984, Mar-03, Volume: 114, Issue:9

    Topics: Adolescent; Adult; Aged; Blood Vessel Prosthesis; Cardiovascular Diseases; Cefazolin; Cefuroxime; Ce

1984

Other Studies

1 other study available for cefuroxime and Heart Valve Diseases

ArticleYear
Prevention of infective endocarditis associated with dental treatment and other medical interventions. National Heart Foundation.
    The New Zealand dental journal, 1999, Volume: 95, Issue:421

    Topics: Adult; Anti-Obesity Agents; Antibiotic Prophylaxis; Aortic Valve Insufficiency; Cefuroxime; Cephalos

1999